NCT03506542View on ClinicalTrials.gov

Phacotrabeculectomy With Collagen Matrix Implant (Ologen®) Versus Mitomycin C

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

June 2, 2014

Primary Completion Date

March 1, 2016

Study Completion Date

March 30, 2017

Conditions
GlaucomaCataractWound Heal
Interventions
DEVICE

Ologen

Ologen implant placed over scleral flap during the surgery to avoid usage of Mitomycin C

PROCEDURE

Phacotrabeculectomy

Trabeculectomy with cataract extraction

DRUG

Mitomycin C

Mitomycin C 0.3 mg/ml for 3 minutes during the surgery (standard procedure)

All Listed Sponsors
collaborator

Aeon Astron Europe B.V.

INDUSTRY

lead

Medical University of Lublin

OTHER

NCT03506542 - Phacotrabeculectomy With Collagen Matrix Implant (Ologen®) Versus Mitomycin C | Biotech Hunter | Biotech Hunter